Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer
Host: Javier Cortes, MD, PhD
Guest: Giuseppe Curigliano, MD, PhD
Guest: Peter Schmid, FRCP, MD, PhD
Skepticism regarding the use of real-world evidence continues to exist among oncologists, but in actuality, real-world studies can provide information that may aid clinicians in Europe who are treating patients with HR-positive/HER2-negative metastatic breast cancer, especially regarding the use of CDK 4/6 inhibitors.
This discussion focuses on the fundamental value that real-world evidence can provide in support of randomized clinical trials and how oncologists can best incorporate these data into current clinical practice.